Investor Presentaiton

We are leveraging expertise to enable expansion beyond Hematology while increasing manufacturing efficiency Wave 1 Single CAR binder Wave 2 Dual CAR binder Wave 3 Multiple other KO/KI Dual CAR binder TCR KO Next-gen engineering Evolving delivery systems Optimizing manufacturing Ill Bristol Myers Squibb™ Monospecific CAR Surface GP200 Tran) MA (matrial Prote A p Dual Targeting CAR 3 VV NC nucleocap СА Lentivirus (LVV) MHC-I KO MHC-II KO Engineered CAR/TCR electroporation MINIMIN DNA MIN MINIMIM Adeno-associated virus (AAV) Lipid nanoparticles (LNP) Non-viral delivery (NVD) Not for Product Promotional Use 43

View entire presentation